Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BMS3013 Diseases of the Human Nervous System > Lecture 22 - Introduction to Movement Disorders > Flashcards

Lecture 22 - Introduction to Movement Disorders Flashcards

1
Q

What are movement disorders?

A

Clinical disorders associated with basal ganglia disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can movement disorders be sub-divided into?

A

Too little movement (hypo kinetic disorders)
Too much movement (hyperkinetic disorders)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Parkinson’s disease?

A

A degeneration disease characterised by a group of cardinal features that include rigidity, resting tremor, slowness in movement (bradykinesia) and balance problems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is Parkinson’s and Lewy body dementia linked?

A

The main proteins involved in both are alpha-synuclein deposits in the brain.
LBD patients eventually get PD and PD patients sometimes get LBD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why do PD patients lose their smell and taste?

A

Basal monoamines in the brainstem are affected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does the basal ganglia contain?

A

Putamen
External globus pallidus (GPe)
Internal globus pallidus (GPi)
Substantia nigra
Subthalamic nucleus (STN)
Thalamus
Caudate nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where is the basal ganglia located in the brain?

A

Cerebrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the loops in the basal ganglia.

A

Four largely segregated cortical loops that have some cross talk.
Links the basal ganglia to the limbic system so movement selection can be informed by emotional and motivational state.
Links to the frontal lobe so that it is receiving proprioceptive feedback of ongoing motor activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the direct pathway in the basal ganglia.

A

Striatum to GPi directly.
Activation = GPi inhibition > thalamic disinhibition > cortical activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the indirect pathway in the basal ganglia.

A

Striatum to GPi indirectly via GPI and STN. GPi activation > thalamic inhibition > cortical inhibition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the direct pathway in the basal ganglia facilitate?

A

The activation of desired movement pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does the indirect pathway in the basal ganglia facilitate?

A

The activation of inappropriate/conflicting movement pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is overactivity of the GPi predicted to cause?

A

A reduced activation of desired movements - bradykinesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is under activity of the GPi predicted to cause?

A

Excessive activation of undesired movements - chorea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the causes of Parkinson’s symptoms?

A

Parkinson’s disease
Drugs such as anti-dopaminergics
Cerebrovascular disease
Structural lesion in the basal ganglia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 4 main clinical signs of PD?

A

Tremor
Bradykinesia
Problems with initiating movements
Postural instability

17
Q

What are the 2 separate groups of tremors?

A

Rest
Postural

18
Q

Describe the pathophysiology of bradykinesia.

A

Normally dopaminergic fibres stimulate the direct pathway via D1 receptors and inhibit the indirect pathway via D2 receptors.
In bradykinesia the direct (activating) pathway becomes underactive and the indirect pathway (inhibitory) pathway becomes overactive leading to an overactive GPi.
The overactive GPi inhibits the motor thalamus and cortex leading to reduced cortical activity > bradykinesia.

19
Q

Describe the relationship between bradykinesia and abnormal oscillatory basal ganglia activity.

A

Excessive beta band oscillations seen in LFPs of PD patients.
The strong, extensive synchronisation in beta bands prevents neurons coding information in time and space.
The pathological oscillations cause distributed cortical activation that degrades movements.

20
Q

Describe levodopa as a treatment for Parkinson’s.

A

Dopamine is the key drug as it is the main chemical that is dropped in PD, but high doses of dopamine can’t be given as it is involved in too many other things.
So, the dopamine precursor levodopa (LDOPA) is given as it can cross the BBB and be taken up into nigral neurons, decarboxylates into dopamine, released into the synaptic cleft to activate post stratal dopamine receptors.

21
Q

Describe deep brain stimulation (DBS) as a treatment for PD.

A

DBS can block the output of the STN or GPi and reduces the level of inhibition and improves bradykinesia.
Stimulation frequency and amplitude titrated against clinical impairment.
The stimulating electrode blocks the firing of neurons in its vicinity.
DBS of the striatum and GPi is effective in treating advanced pD.

22
Q

Describe hyperkinetic disorders.

A

A heterogenous group of diseases that are characterised by the presence of excessive involuntary movements with a range of different clinical manifestations.
Characteristic of a tic is that it can be suppressed to a certain extent.

23
Q

What is Huntington’s disease?

A

Autosomal dominant genetic condition with excess Huntington gene (Chr4p) causing there to be excess Huntington protein which causes excessive movement.

24
Q

What are the clinical features of Huntington’s disease?

A

Chorea
Dementia
Anxiety
Depression

25
Q

Describe the Huntington gene.

A

Chromosome 4p.
CAG repeat at N terminus, <36 repeats = unaffected, 36-40 repeats = reduced penetrance, >40 repeats = full penetrance.
CAG repeat explains 60% of onset variability, the more repeats, the younger the onset.

26
Q

Describe inclusions in Huntington’s disease.

A

Mutantform of Huntingtin (Htt) with repeated glutamine residues.
These aggregate to form inclusion bodies.

27
Q

Describe pathology of Huntington’s.

A

Atrophy of the striatum (caudate and putamen)
Particularly affects spiny neurons projecting from the putamen to GPe.

28
Q

What is the mechanism of chorea?

A

Degeneration of indirect pathway leads to disinhibition of motor thalamus and over-activation of inappropriate motor commands.

29
Q

What is dystonia?

A

Loss of precise movement.
Involuntary, sustained muscle contractions leading to abnormal postures and repetitive movements.
Non-degenrative disorder, just happens and manifests with precise movements.

30
Q

What are the 3 types of classification for dystonia?

A

Primary (genetic) dystonia
Secondary dystonia - due to structural lesions, metabolic disease and hereditary degenerative disorders.

31
Q

Describe primary torsion dystonia.

A

Initially mapped to DYTI locus on chromosome 8.
Gene codes for Torsin A (heat shock protein)
30% penetrance
Presents in childhood with lower limb dystonia and then subsequent generalisation.

32
Q

Where are almost all the lesions that cause dystonia located?

A

Basal ganglia

33
Q

What did animal models with a basal ganglia lesion show?

A

Reduced functional activity and grey matter volume on MRI.
Neuronal activity in GPi correlated with dystonic EMG activity

BMS3013 Diseases of the Human Nervous System (26 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions